simvastatin has been researched along with Coagulation Disorders, Blood in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Du, MY; Hu, Y; Luo, LL; Mei, H; Tang, L; Xu, M; Zhou, J | 1 |
Audebert, H; Haberl, RL | 1 |
Neild, GH | 1 |
Bauer, EP; Haberbosch, W; Hilgendorff, A; Hölschermann, H; Kemkes-Matthes, B; Schönburg, M; Tillmanns, H | 1 |
1 review(s) available for simvastatin and Coagulation Disorders, Blood
Article | Year |
---|---|
[Secondary prevention after stroke: healthy life style, oral anticoagulation].
Topics: Administration, Oral; Adult; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Blood Coagulation Disorders; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Clinical Trials as Topic; Contraceptives, Oral; Embolism; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Ischemic Attack, Transient; Life Style; Male; Phenprocoumon; Platelet Aggregation Inhibitors; Recurrence; Simvastatin; Smoking Cessation; Stroke | 2003 |
3 other study(ies) available for simvastatin and Coagulation Disorders, Blood
Article | Year |
---|---|
Simvastatin Improves Outcomes of Endotoxin-induced Coagulopathy by Regulating Intestinal Microenvironment.
Topics: Animals; Blood Coagulation Disorders; Disease Models, Animal; Endotoxemia; Endotoxins; Gastrointestinal Microbiome; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Diseases; Male; Mice; Mice, Inbred C57BL; Simvastatin | 2022 |
Statins for all.
Topics: Blood Coagulation; Blood Coagulation Disorders; Coronary Disease; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2000 |
Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients.
Topics: Adult; Aged; Blood Coagulation Disorders; Coronary Disease; Female; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Monocytes; RNA, Messenger; Simvastatin; Thromboplastin | 2000 |